Drugs & Pharmaceuticals

Xarelto (rivaroxaban)

Xarelto is a prescription pain medication first approved by the FDA in July of 2011. The drug is co-marketed by Bayer and Johnson & Johnson. The medication is prescribed for three primary purposes: reducing the risk of strokes and blood clots after a diagnosis of atrial fibrillation; reducing the risk of blood clot and stroke when patients undergo knee replacement or hip replacement procedures; and treatment of pulmonary embolisms or deep vein thrombosis.

Individuals taking Xarelto have suffered various bleeding events leading to death. Lawyers are pursuing cases where Xarelto users have suffered injuries such as pulmonary embolism, deep vein thrombosis, gastrointestinal hemorrhage and hemorrhage and death.


This is Attorney Advertising
TheClassActionNews.com is operated by the Law Offices of Jennifer Duffy, A Professional Law Corporation. Main Office: 4601 Wilshire Blvd, Los Angeles, CA 90010

We invite you to contact us and welcome your calls, letters and electronic mail. Contacting us does not create an attorney-client relationship. Please do not send any confidential information to us until such time as an attorney-client relationship has been established.

The hiring of a lawyer is an important decision that should not be based solely upon advertisements. No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers. Prior results do not guarantee a similar outcome. Submission of our contact form is an agreement to receive communication from entities related to TheClassActionNews.com. While the firm maintains joint responsibility, some cases are referred to other attorneys for principle responsibility.
Show More

Related Articles